Correlation plots between the rate of change (RC) in the (%) inhibition... | Download Scientific Diagram
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast
Prof. Ioannis P. TROUGAKOS – Mu.Ta.Lig – COST ACTION CA15135
PDF) Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Biomedicine Archives - Page 2 of 3 - Neuro-Psychology
Universal Design: A Step toward Successful Aging – topic of research paper in Psychology. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Home
Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection | Immunology
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Vaccines | Free Full-Text | SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
Ioannis Trougakos
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine | SpringerLink
Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual Laboratory
Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books - Amazon.com
Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine - Terpos - 2021 - American Journal of Hematology - Wiley Online Library
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment - Abstract - Europe PMC
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Natural compounds with anti-ageing activity - Natural Product Reports (RSC Publishing) DOI:10.1039/C3NP70031C
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Olive Bioactives: applications and prospects | LE STUDIUM
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Amazon.com: Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books
